Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus

Biomarkers in Medicine

Volumn 3, Issue 6, 2009, Pages 787-805

  Tarnaris, Andrew ^a   Toma, Ahmed K ^a   Kitchen, Neil D ^a   Watkins, Laurence D ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Biomarkers; CSF; Diagnosis; Imaging; Normal pressure hydrocephalus; Parkinson's disease; Vascular dementia

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CYTOKINE; LACTIC ACID; NEUROFILAMENT PROTEIN; NEUROPEPTIDE; SULFATIDE; TAU PROTEIN; TUMOR NECROSIS FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMAGE DISPLAY; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 75149145211     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.09.37     Document Type: Review

References (200)

1. Ishikawa M, Hashimoto M, Kuwana N et al.: Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol. Med. Chir. (Tokyo) 48(Suppl.), 1-23 (2008).
2. Scollato A, Tenenbaum R, Bahl G, Celerini M, Salani B, Di Lorenzo N: Changes in aqueductal CSF stroke volume and progression of symptoms in patients with unshunted idiopathic normal pressure hydrocephalus. AJNR Am. J. Neuroradiol. 29(1), 192 (2008).
3. Bateman GA: Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer's disease, vascular dementia and normal pressure hydrocephalus. Med. Hypotheses 62(2), 182-187 (2004). ■■ Hypothesis that trys to explain a common pathophysiological pathway for all three conditions.
4. Chakravarty A: Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis. Med. Hypotheses 63(5), 827-833 (2004).
5. Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM: The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus. Neurosurgery 57(3 Suppl.), S17-S28; discussion ii-v (2005). ■■ The section from the international guidelines reviewing the supplementary prognostic tests in idiopathic normal pressure hydrocephalus (NPH).
6. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D: Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol. 2(8), 506-511 (2003). ■■ Hypothesis that presents both NPH and Alzheimer's dementia (AD) as two spectra of cerebrospinal fluid (CSF) circulatory failure.
7. George AE, Holodny A, Golomb J, de Leon MJ: The differential diagnosis of Alzheimer's disease. Cerebral atrophy versus normal pressure hydrocephalus. Neuroimaging Clin. N. Am. 5(1), 19 (1995).
8. Batra S, Rigamonti D: Idiopathic normal pressure hydrocephalus: the benefits and problems of shunting. Nat. Clin. Pract. Neurol. 5(2), 80-81 (2009).
9. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM: Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57(3 Suppl.), S4-S16; discussion ii-v (2005). ■■ Diagnostic criteria from the international guidelines in idiopathic NPH published in 2005.
10. Mori K, Mima T: To what extent has the pathophysiology of normal-pressure hydrocephalus been clarified. Crit. Rev. Neurosurg. 8(4), 232-243 (1998).
11. Shaw LM, Korecka M, Clark CM, Lee VMY, Trojanowski JQ: Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat. Rev. Drug Discov. 6(4), 295-303 (2007).
12. Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol. Aging 19(2), 109-116 (1998).
13. Tarnaris A, Kitchen ND, Watkins LD: Noninvasive biomarkers in normal pressure hydrocephalus: evidence for the role of neuroimaging. J. Neurosurg. 110(5), 837-851 (2009). ■ Evidenced-based review suggesting neuroimaging modalities as prognostic biomarkers for favorable surgical outcomes.
14. Tarnaris A, Watkins LD, Kitchen ND: Biomarkers in chronic adult hydrocephalus. Cerebrospinal Fluid Res. 3(1), 11 (2006). ■ First to reassess the value of CSF markers in predicting surgical response in NPH.
15. Hammer M, Sørensen PS, Gjerris F, Larsen K: Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. Eur. J. Endocrinol. 100(2), 211 (1982).
16. Catalan R, Sahuquillo J, Poca MA, Molins A, Castellanos JM, Galard R: Neuropeptide Y cerebrospinal fluid levels in patients with normal pressure hydrocephalus syndrome. Biol. Psychiatry 36(1), 61-63 (1994).
17. Golomb J, Wisoff J, Miller DC et al.: Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J. Neurol. Neurosurg. Psychiatr. 68(6), 778-781 (2000). ■ Examines the important issue of the prevalence of AD comorbidity in patients with NPH.
18. Kapaki EN, Paraskevas GP, Tzerakis NG et al.: Cerebrospinal fluid tau, phospho-tau 181 and β-amyloid 1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease. Eur. J. Neurol. 14(2), 168-173 (2007).
19. Agren-Wilsson A, Lekman A, Sjoberg W et al.: CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol. Scand. 116(5), 333-339 (2007). ■ Well-designed study in patients with idiopathic NPH examing the diagnostic value of several CSF biomarkers.
20. Wikkelso C, Blomstrand C: Cerebrospinal fluid proteins and cells in normal-pressure hydrocephalus. J. Neurol. 228(3), 171-180 (1982). ■■ One of the very first studies that initiated in the discovery of CSF biomarkers in NPH.
21. Vanneste JA: Three decades of normal pressure hydrocephalus: are we wiser now? BMJ 57(9), 1021-1025 (1994).
22. Black PM, Ojemann RG, Tzouras A: CSF shunts for dementia, incontinence, and gait disturbance. Clin. Neurosurg. 32, 632 (1985).
23. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI: Abnormal phosphorylation of the microtubule-associated protein (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83(13), 4913-4917 (1986).
24. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82(4), 239-259 (1991).
25. Kudo T, Mima T, Hashimoto R et al.: Tau protein is a potential biological marker for normal pressure hydrocephalus. Psychiatry Clin. Neurosci. 54(2), 199-202 (2000).
26. Zemlan FP, Rosenberg WS, Luebbe PA et al.: Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J. Neurochem. 72(2), 741 (1999).
27. Lins H, Wichart I, Bancher C, Wallesch CW, Jellinger KA, Rosler N: Immunoreactivities of amyloid β peptide (1-42) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus. J. Neural Transm. 111(3), 273-280 (2004).
28. Gloeckner SF, Meyne F, Wagner F et al.: Quantitative analysis of transthyretin, tau and amyloid-β in patients with dementia. J. Alzheimers Dis. 14(1), 17-25 (2008).
29. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 26(3), 231 (1995).
30. Rösler N, Wichart I, Jellinger KA: Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. J. Neural Transm. 108(2), 231-246 (2001).
31. Mazurek MF: CSF vasopressin concentration is reduced in Alzheimer's disease. Neurology 36(8), 1133-1137 (1986).
32. Sørensen PS, Hammer M, Vorstrup S, Gjerris F: CSF and plasma vasopressin concentrations in dementia. BMJ 46(10), 911-916 (1983).
33. Sørensen PS, Gjerris F, Ibsen S, Bock E: Low cerebrospinal fluid concentration of brain-specific protein D2 in patients with normal pressure hydrocephalus. J. Neurol. Sci. 62(1-3), 59 (1983).
34. Cramer H, Schaudt D, Rissler K, Strubel D, Warter JM, Kuntzmann F: Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus. J. Neurol. 232(6), 346-351 (1985).
35. Molins A, Catalan R, Sahuquillo J, Castellanos JM, Codina A, Galard R: Somatostatin cerebrospinal fluid levels in dementia. J. Neurol. 238(3), 168-170 (1991).
36. Ahlberg J, Blomstrand C, Ronquist G, Wikkelso C: Dementia and adenylate kinase activity in cerebrospinal fluid. Acta Neurol. Scand. 72(5), 525-527 (1985).
37. Albrechtsen M, Sørensen PS, Gjerris F, Bock E: High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus. J. Neurol. Sci. 70(3), 269-274 (1985).
38. Wikkelso C: Dementia of different etiologies: vasoactive intestinal polypeptide in CSF. Neurology 35(4), 592-595 (1985).
39. Brettschneider J, Riepe MW, Petereit HF, Ludolph AC, Tumani H: Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus? J. Neurol. Neurosurg. Psychiatr. 75(11), 1614-1616 (2004).
40. Laske C, Stransky E, Leyhe T et al.: BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J. Psychiatr. Res. 41(5), 387-394 (2007).
41. Cacabelos R, Barquero M, Garcia P, Alvarez XA, Varela de Seijas E: Cerebrospinal fluid interleukin-1β (IL-1β) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 13(7), 455 (1991).
42. Nooijen PT, Schoonderwaldt HC, Wevers RA, Hommes OR, Lamers KJ: Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia. Dement. Geriatr. Cogn. Disord. 8(3), 169-173 (1997).
43. Malm J, Kristensen B, Ekstedt J, Adolfsson R, Wester P: CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters. J. Neurol. Neurosurg. Psychiatr. 54(3), 252-259 (1991).
44. Tullberg M, Mansson JE, Fredman P et al.: CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy. J. Neurol. Neurosurg. Psychiatr. 69(1), 74-81 (2000).
45. Tullberg M, Hultin L, Ekholm S, Mansson JE, Fredman P, Wikkelso C: White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol. Scand. 105(6), 417-426 (2002).
46. Petzold A, Keir G, Warren J, Fox N, Rossor MN: A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. Neurodegener. Dis. 4(2-3), 185-194 (2007).
47. Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J. Neurochem. 67(5), 2013 (1996).
48. Wikkelso C, Ekman R, Westergren I, Johansson B: Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. Eur. Neurol. 31(2), 88-93 (1991).
49. Mario Delgado NVEG-R: Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels. Glia 56(10), 1091-1103 (2008).
50. Mase M, Yamada K, Shimazu N et al.: Lipocalin-type prostaglandin D synthase (β-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus. Neurosci. Res. 47(4), 455-459 (2003).
51. Stolze H, Klebe S, Baecker C et al.: Prevalence of gait disorders in hospitalized neurological patients. Mov. Disord. 20(1) (2005).
52. Espay AJ, Narayan RK, Duker AP, Barrett ET Jr, de Courten-Myers G: Lower-body parkinsonism: reconsidering the threshold for external lumbar drainage. Nat. Clin. Pract. Neurol. 4(1), 50-55 (2008).
53. Mandir AS, Hilfiker J, Thomas G et al.: Extrapyramidal signs in normal pressure hydrocephalus: an objective assessment. Cerebrospinal Fluid Res. 4(1), 7 (2007).
54. Krauss JK, Regel JP, Droste DW, Orszagh M, Borremans JJ, Vach W: Movement disorders in adult hydrocephalus. Mov. Disord. 12(1), 53-60 (1997).
55. Stolze H, Kuhtz-Buschbeck JP, Drucke H, Johnk K, Illert M, Deuschl G: Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 70(3), 289-297 (2001).
56. Beal MF: CSF somatostatin-like immunoreactivity in dementia. Neurology 36(2), 294-297 (1986).
57. Ferrero P, Benna P, Costa P et al.: Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CSF: correlations with neurological disorders. J. Neurol. Sci. 87(2-3), 327-349 (1988).
58. Arai H, Terajima M, Miura M et al.: Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann. Neurol. 38(4) (1995).
59. Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson's disease. Science 302(5646), 819-822 (2003).
60. Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P: Increased intrathecal TGF-α1, but not IL-12, IFN-α and IL-10 levels in Alzheimer's disease patients. Neurol. Sci. 27(1), 33-39 (2006).
61. Benzel E, Pelletier A, Levy P: Communicating hydrocephalus in adults: prediction of outcome after ventricular shunting procedures. Neurosurgery 26(4), 655-660 (1990).
62. Borgesen S, Gjerris F: The predictive value of conductance to outflow of CSF in normal pressure hydrocephalus. Brain 105(1), 65-86 (1982).
63. Poca MA, Mataro M, Del Mar Matarin M, Arikan F, Junque C, Sahuquillo J: Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure. J. Neurosurg. 100(5), 855-866 (2004).
64. Kitagaki H: CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am. J. Neuroradiol. 19(7), 1277-1284 (1998).
65. Sasaki M, Honda S, Yuasa T, Iwamura A, Shibata E, Ohba H: Narrow CSF space at high convexity and high midline areas in idiopathic normal pressure hydrocephalus detected by axial and coronal MRI. Neuroradiology 50(2), 117-122 (2008).
66. Ishii K, Kawaguchi T, Shimada K et al.: Voxel-based analysis of gray matter and CSF space in idiopathic normal pressure hydrocephalus. Dement. Geriatr. Cogn. Disord. 25(4), 329-335 (2008).
67. Bradley W Jr: MR prediction of shunt response in NPH: CSF morphology versus physiology. AJNR Am. J. Neuroradiol. 19(7), 1285-1286 (1998).
68. Ishikawa M, Suzuki T, Ohwaki H, Matsumoto A: Is it possible to make a diagnosis of idiopathic normal pressure hydrocephalus on MRI/CT? Jpn. J. Neurosurg. 15(9), 619 (2006).
69. Bateman G, Loiselle A: Can MR measurement of intracranial hydrodynamics and compliance differentiate which patient with idiopathic normal pressure hydrocephalus will improve following shunt insertion? Acta Neurochir (Wien) 149(5), 455-462 (2007).
70. Ishii K, Kanda T, Harada A et al.: Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur. Radiol. 18(11), 2678-2683 (2008).
71. Holodny A: MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. AJNR Am. J. Neuroradiol. 19(5), 813-819 (1998).
72. Adachi M, Kawanami T, Ohshima F, Kato T: Upper midbrain profile sign and cingulate sulcus sign: MRI findings on sagittal images in idiopathic normal-pressure hydrocephalus, Alzheimer's disease, and progressive supranuclear palsy. Radiat. Med. 24(8), 568-572 (2006).
73. Qureshi AI, Williams MA, Razumovsky AY, Hanley DF: Magnetic resonance imaging, unstable intracranial pressure and clinical outcome in patients with normal pressure hydrocephalus. Acta Neurochir. Suppl. 71, 354-356 (1998).
74. Mataro M, Matarin M, Poca M et al.: Functional and magnetic resonance imaging correlates of corpus callosum in normal pressure hydrocephalus before and after shunting. BMJ 78(4), 395-398 (2007).
75. Jack C, Mokri B, Laws E, Houser O, Baker H, Petersen R: MR findings in normal-pressure hydrocephalus: significance and comparison with other forms of dementia. J. Comput. Assist. Tomogr. 11(6), 923-931 (1987).
76. Lee P, Yong S, Ahn Y, Huh K: Correlation of midbrain diameter and gait disturbance in patients with idiopathic normal pressure hydrocephalus. J. Neurol. 252(8), 958-963 (2005).
77. Mocco J, Tomey M, Komotar R et al.: Ventriculoperitoneal shunting of idiopathic normal pressure hydrocephalus increases midbrain size: a potential mechanism for gait improvement. Neurosurgery 59(4), 847-851 (2006).
78. Yamada F, Fukuda S, Samejima H, Yoshii N, Kudo T: Significance of pathognomonic features of normal-pressure hydrocephalus on computerized tomography. Neuroradiology 16(1), 212-213 (1978).
79. Aygok G, Marmarou A, Fatouros P, Young H: Brain tissue water content in patients with idiopathic normal pressure hydrocephalus. Acta Neurochir. Suppl. 96, 348-351 (2006).
80. Poca M, Mataró M, del Mar Matarin M, Arikan F, Junqué C, Sahuquillo J: Is the placement of shunts in patients with idiopathic normal pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure. J. Neurosurg. 100(5), 855-866 (2004).
81. Thomsen AM, Børgesen SE, Bruhn P, Gjerris F: Prognosis of dementia in normalpressure hydrocephalus after a shunt operation. Ann. Neurol. 20(3), 304-310 (1986).
82. Akiguchi I, Ishii M, Watanabe Y et al.: Shunt-responsive Parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J. Neurol. 255(9), 1392-1399 (2008).
83. Bradley W Jr: Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normalpressure hydrocephalus. AJNR Am. J. Neuroradiol. 12(1), 31-39 (1991).
84. Krauss J, Regel J, Vach W et al.: White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an agematched control group: a comparative study. Neurosurgery 40(3), 491 (1997).
85. Hähnel S, Freund M, Münkel K et al.: Magnetisation transfer ratio is low in normal-appearing cerebral white matter in patients with normal pressure hydrocephalus. Neuroradiology 42(3), 174-179 (2000).
86. Tullberg M, Hultin L, Ekholm S, Mansson J, Fredman P, Wikkelso C: White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination. Acta Neurol. Scand. 105(6), 417 (2002).
87. Bugalho P, Alves L: Normal-pressure hydrocephalus: white matter lesions correlate negatively with gait improvement after lumbar puncture. Clin. Neurol. Neurosurg. 109(9), 774-778 (2007).
88. Krauss J, Droste D, Vach W et al.: Cerebrospinal fluid shunting in idiopathic normal-pressure hydrocephalus of the elderly: effect of periventricular and deep white matter lesions. Neurosurgery 39(2), 292 (1996).
89. Tullberg M, Jensen C, Ekholm S, Wikkelso C: Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR Am. J. Neuroradiol. 22(9), 1665-1673 (2001).
90. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM: Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57(3 Suppl.), S4-S16; discussion ii-v (2005).
91. Matsumae M, Kikinis R, Morocz I et al.: Intracranial compartment volumes in patients with enlarged ventricles assessed by magnetic resonance-based image processing. J. Neurosurg. 84(6), 972-981 (1996).
92. Bradley W, Safar F, Hurtado C, Ord J, Alksne J: Increased intracranial volume: a clue to the etiology of idiopathic normalpressure hydrocephalus? AJNR Am. J. Neuroradiol. 25(9), 1479-1484 (2004).
93. Tsunoda A, Mitsuoka H, Bandai H, Arai H, Sato K, Makita J: Intracranial cerebrospinal fluid distribution and its postoperative changes in normal pressure hydrocephalus. Acta Neurochir (Wien) 143(5), 493-499 (2001).
94. Yoshihara M, Tsunoda A, Sato K, Kanayama S, Calderon A: Differential diagnosis of NPH and brain atrophy assessed by measurement of intracranial and ventricular CSF volume with 3D FASE MRI. Acta Neurochir. Suppl. 71, 371-374 (1998).
95. Tsunoda A, Mitsuoka H, Sato K, Kanayama S: A quantitative index of intracranial cerebrospinal fluid distribution in normal pressure hydrocephalus using an MRI-based processing technique. Neuroradiology 42(6), 424-429 (2000).
96. Palm WM, Walchenbach R, Bruinsma B et al.: Intracranial compartment volumes in normal pressure hydrocephalus: volumetric assessment versus outcome. Am. Soc. Neuroradiol. 27, 76-79 (2006)
97. Anderson R, Grant J, de la Paz R, Frucht S, Goodman R: Volumetric measurements in the detection of reduced ventricular volume in patients with normal-pressure hydrocephalus whose clinical condition improved after ventriculoperitoneal shunt placement. J. Neurosurg. 97(1), 73 (2002).
98. Meier U, Mutze S: Correlation between decreased ventricular size and positive clinical outcome following shunt placement in patients with normal-pressure hydrocephalus. J. Neurosurg. 100(6), 1036 (2004).
99. Meier U, Paris S, Gräwe A, Stockheim D, Hajdukova A, Mutze S: Is there a correlation between operative results and change in ventricular volume after shunt placement? A study of 60 cases of idiopathic normal-pressure hydrocephalus. Neuroradiology 45(6), 377-380 (2003).
100. Meier U, Paris S, Grawe A, Stockheim D, Hajdukova A, Mutze S: Is decreased ventricular volume a correlate of positive clinical outcome following shunt placement in cases of normal pressure hydrocephalus? Acta Neurochir. Suppl. 86, 533-537 (2003).
101. Chatzidakis E, Barlas G, Condilis N et al.: Brain CT scan indexes in the normal pressure hydrocephalus: predictive value in the outcome of patients and correlation to the clinical symptoms. Ann. Ital. Chir. 79(5), 353-362 (2008).
102. Wikkelso C, Andersson H, Blomstrand C, Matousek M, Svendsen P: Computed tomography of the brain in the diagnosis of and prognosis in normal pressure hydrocephalus. Neuroradiology 31(2), 160-165 (1989).
103. Holodny A, George A, De Leon M, Golomb J, Kalnin A, Cooper P: Focal dilation and paradoxical collapse of cortical fissures and sulci in patients with normal-pressure hydrocephalus. J. Neurosurg. 89(5), 742 (1998).
104. Ishii K, Kanda T, Harada A et al.: Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur. Radiol. 18(11), 2678-2683 (2008).
105. Golomb J, De Leon M, George A et al.: Hippocampal atrophy correlates with severe cognitive impairment in elderly patients with suspected normal pressure hydrocephalus. BMJ 57(5), 590-593 (1994).
106. Savolainen S, Laakso M, Paljarvi L et al.: MR imaging of the hippocampus in normal pressure hydrocephalus: correlations with cortical Alzheimer's disease confirmed by pathologic analysis. AJNR Am. J. Neuroradiol. 21(2), 409-414 (2000).
107. DeVito E, Salmond C, Owler B, Sahakian B, Pickard J: Caudate structural abnormalities in idiopathic normal pressure hydrocephalus. Acta Neurol. Scand. 116(5), 328 (2007).
108. Bakker S, Boon A, Wijnhoud A, Dippel D, Delwel E, Koudstaal P: Cerebral hemodynamics before and after shunting in normal pressure hydrocephalus. Acta Neurol. Scand. 106(3), 123 (2002).
109. Fritz W, Kalbarczyk H, Schmidt K: Transcranial Doppler sonographic identification of a subgroup of patients with normal pressure hydrocephalus with coexistent vascular disease and treatment failure. Neurosurgery 25(5), 777-780 (1989).
110. Krauss J, Droste D: Predictability of intracranial pressure oscillations in patients with suspected normal pressure hydrocephalus by transcranial Doppler ultrasound. Neurol. Res. 16(5), 398-402 (1994).
111. Owler B, Pickard J: Normal pressure hydrocephalus and cerebral blood flow: a review. Acta Neurol. Scand. 104(6), 325 (2001). ■■ Comprehensive review of the issue of cerebral blood flow in NPH.
112. Kristensen B, Malm J, Fagerland M et al.: Regional cerebral blood flow, white matter abnormalities, and cerebrospinal fluid hydrodynamics in patients with idiopathic adult hydrocephalus syndrome. BMJ 60(3), 282-288 (1996).
113. Larsson A, Bergh A, Bilting M et al.: Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur. J. Nucl. Med. Mol. Imaging 21(2), 118-123 (1994).
114. Mamo H, Meric P, Ponsin J, Rey A, Luft A, Seylaz J: Cerebral blood flow in normal pressure hydrocephalus. Stroke 18(6), 1074-1080 (1987).
115. Meyer J, Kitagawa Y, Tanahashi N et al.: Pathogenesis of normal-pressure hydrocephalus-preliminary observations. Surg. Neurol. 23(2), 121-133 (1985).
116. Tamaki N, Kusunoki T, Wakabayashi T, Matsumoto S: Cerebral hemodynamics in normal-pressure hydrocephalus. Evaluation by 133Xe inhalation method and dynamic CT study. J. Neurosurg. 61(3), 510-514 (1984).
117. Vorstrup S, Christensen J, Gjerris F, Sørensen P, Thomsen A, Paulson O: Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting. J. Neurosurg. 66(3), 379 (1987).
118. Baba M, Takeyama E, Beppu T, Jimbo M, Kitamura K: [Normal pressure hydrocephalus. Part 2. The evaluation of severity of cerebral dysfunction by measurement of "barrier ratio" and regional cerebral blood flow (author's transl)]. No To Shinkei 30(6), 697 (1978)).
119. Owler BK, Pena A, Momjian S: Changes in cerebral blood flow during cerebrospinal fluid pressure manipulation in patients with normal pressure hydrocephalus: a methodological study. J. Cereb. Blood Flow Metab. 24(5), 579-587 (2004).
120. Owler BK, Momjian S, Czosnyka Z et al.: Normal pressure hydrocephalus and cerebral blood flow: a PET study of baseline values. J. Cereb. Blood Flow Metab. 24(1), 17-23 (2004).
121. Tullberg M, Hellstrom P, Piechnik S, Starmark J, Wikkelso C: Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus. Acta Neurol. Scand. 110(5), 322 (2004).
122. Takeuchi T, Goto H, Izaki K et al.: Pathophysiology of cerebral circulatory disorders in idiopathic normal pressure hydrocephalus. Neurol. Med. Chir. (Tokyo) 47(7), 299-306 (2007).
123. Nakano H, Bandoh K, Miyaoka M, Sato K: Evaluation of hydrocephalic periventricular radiolucency by dynamic computed tomography and xenon-computed tomography. Neurosurgery 39(4), 758 (1996).
124. Matsuda M, Nakasu S, Nakazawa T, Handa J: Cerebral hemodynamics in patients with normal pressure hydrocephalus: correlation between cerebral circulation time and dementia. Surg. Neurol. 34(6), 396 (1990).
125. Kimura M, Tanaka A, Yoshinaga S: Significance of periventricular hemodynamics in normal pressure hydrocephalus. Neurosurgery 30(5), 701 (1992).
126. Kushner M: Cerebral hemodynamics in the diagnosis of normal pressure hydrocephalus. Neurology 34(1), 96-99 (1984).
127. Maeder P, Tribolet N: Xenon CT measurement of cerebral blood flow in hydrocephalus. Childs Nerv. Syst. 11(7), 388-391 (1995).
128. Shimoda M, Oda S, Shibata M, Masuko A, Sato O: Change in regional cerebral blood flow following glycerol administration predicts. Acta Neurochir (Wien) 129(3), 171-176 (1994).
129. Tanaka A, Kimura M, Nakayama Y, Yoshinaga S, Tomonaga M: cerebral blood flow and autoregulation in normal pressure hydrocephalus. Neurosurgery 40(6), 1161 (1997).
130. 18F fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. BMJ 48(11), 1091-1096 (1985).
131. Ishikawa M, Kikuchi H, Taki W et al.: Regional cerebral blood flow and oxygen metabolism in normal pressure hydrocephalus after subarachnoid hemorrhage. Neurol. Med. Chir. (Tokyo) 29(5), 382-388 (1989).
132. Momjian S, Owler B, Czosnyka Z, Czosnyka M, Pena A, Pickard J: Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 127(5), 965 (2004).
133. Klinge P, Berding G, Brinker T et al.: The role of cerebral blood flow and cerebrovascular reserve capacity in the diagnosis of chronic hydrocephalus - a PET-study on 60 patients. Acta Neurochir. Suppl. 81, 39 (2002).
134. Klinge PM, Berding G, Brinker T, Knapp WH, Samii M: A positron emission tomography study of cerebrovascular reserve before and after shunt surgery in patients with idiopathic chronic hydrocephalus. J. Neurosurg. 91(4), 605-609 (1999). ■ Provides insight into the changes occuring following shunting in NPH.
135. Klinge P, Berding G, Brinker T, Weckesser E, Knapp WH, Samii M: Regional cerebral blood flow profiles of shunt-responder in idiopathic chronic hydrocephalus - a 15-O-water PET-study. Acta Neurochir. Suppl. 81, 47-49 (2002).
136. Klinge P, Fischer J, Brinker T et al.: PET and CBF studies of chronic hydrocephalus: a contribution to surgical indication and prognosis. J. Neuroimaging 8(4), 205 (1998).
137. Klinge P, Berding G, Brinker T, Schuhmann M, Knapp WH, Samii M: PET-studies in idiopathic chronic hydrocephalus before and after shunttreatment: the role of risk factors for cerebrovascular disease (CVD) on cerebral hemodynamics. Acta Neurochir. Suppl. 81, 43 (2002).
138. Miyamoto J, Tatsuzawa K, Inoue Y, Imahori Y, Mineura K: Oxygen metabolism changes in patients with idiopathic normal pressure hydrocephalus before and after shunting operation. Mol. Microbiol. 116(3), 137 (2007).
139. Miyamoto J, Imahori Y, Mineura K: Cerebral oxygen metabolism in idiopathic-normal pressure hydrocephalus. Neurol. Res. 29(8), 830-834 (2007).
140. Sasaki H, Ishii K, Kono A et al.: Cerebral perfusion pattern of idiopathic normal pressure hydrocephalus studied by SPECT and statistical brain mapping. Ann. Nucl. Med. 21(1), 39-46 (2007).
141. Piechnik S, Hultin L: Postoperative changes in SPECT-rCBF in hydrocephalus. Acta Neurochir. Suppl. 95, 169-172 (2005)).
142. Mataró M, Poca MA, Salgado-Pineda P et al.: Postsurgical cerebral perfusion changes in idiopathic normal pressure hydrocephalus: a statistical parametric mapping study of SPECT images. J. Nucl. Med. 44(12), 1884-1889 (2003).
143. Hertel F, Walter C, Schmitt M et al.: Is a combination of Tc-SPECT or perfusion weighted magnetic resonance imaging with spinal tap test helpful in the diagnosis of normal pressure hydrocephalus? BMJ 74(4), 479-484 (2003).
144. 123I-IMP SPECT. Neurol. Med. Chir. (Tokyo) 31(8), 503 (1991).
145. 123I] iodoamphetamine. Commentaries. Author's reply. Acta Neurochir. (Wien) 144(3), 255-263 (2002).
146. Dumarey N, Massager N, Laureys S, Goldman S: Voxel-based assessment of spinal tap test-induced regional cerebral blood flow changes in normal pressure hydrocephalus. Nucl. Med. Commun. 26(9), 757 (2005).
147. Graff-Radford N, Rezai K, Godersky J, Eslinger P, Damasio H, Kirchner P: Regional cerebral blood flow in normal pressure hydrocephalus. BMJ 50(12), 1589-1596 (1987).
148. Graff-Radford N: Variables predicting surgical outcome in symptomatic hydrocephalus in the elderly. Neurology 39(12), 1601-1604 (1989).
149. Granado J, Diaz F, Alday R: Evaluation of brain SPECT in the diagnosis and prognosis of the normal pressure hydrocephalus syndrome. Acta Neurochir (Wien) 112(3), 88-91 (1991).
150. 1HMPAO in normal pressure hydrocephalus before and after shunt operation. BMJ 56(6), 655-664 (1993).
151. Hayashi T, Ishikawa M, Moritake K et al.: Prediction of effectiveness of shunting in patients with normal pressure hydrocephalus by cerebral blood flow measurement and computed tomography cisternography. Neurol. Med. Chir. 39(12), 841-846 (1999).
152. Murakami M, Hirata Y, Kuratsu J: Predictive assessment of shunt effectiveness in patients with idiopathic normal pressure hydrocephalus by determining regional cerebral blood flow on 3D stereotactic surface projections. Acta Neurochir (Wien) 149(10), 991-997 (2007).
153. Klinge P, Berding G, Brinker T, Knapp W, Samii M: A positron emission tomography study of cerebrovascular reserve before and after shunt surgery in patients with idiopathic chronic hydrocephalus. Neurosurg. Focus 8(2), 1-5 (2000).
154. Walter C, Hertel F, Naumann E, Mörsdorf M: Alteration of cerebral perfusion in patients with idiopathic normal pressure hydrocephalus measured by 3D perfusion weighted magnetic resonance imaging. J. Neurol. 252(12), 1465-1471 (2005).
155. Corkill R, Garnett M, Blamire A, Rajagopalan B, Cadoux-Hudson T, Styles P: Multi-modal MRI in normal pressure hydrocephalus identifies pre-operative haemodynamic and diffusion coefficient changes in normal appearing white matter correlating with surgical outcome. Clin. Neurol. Neurosurg. 105(3), 193-202 (2003).
156. Anik Y, Demirci A, Anik I, Etus V, Arslan A: Apparent diffusion coefficient and cerebrospinal fluid flow measurements in patients with hydrocephalus. J. Comput. Assist. Tomogr. 32(3), 392 (2008).
157. Bradley Jr W, Kortman K, Burgoyne B: Flowing cerebrospinal fluid in
158. Bradley W Jr, Whittemore A, Kortman K et al.: Marked cerebrospinal fluid void: indicator of successful shunt in patients with suspected normal-pressure hydrocephalus. Radiology 178(2), 459 (1991).
159. Krauss J, Regel J, Vach W, Jüngling F, Droste D, Wakhloo A: Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting? Neurosurgery 40(1), 67 (1997).
160. Mascalchi M: Fast multiphase MR imaging of aqueductal CSF flow: 2. Study in patients with hydrocephalus. AJNR Am. J. Neuroradiol. 11(3), 597-603 (1990).
161. Gideon P, Ståhlberg F, Thomsen C, Gjerris F, Sørensen P, Henriksen O: Cerebrospinal fluid flow and production in patients with normal pressure hydrocephalus studied by MRI. Neuroradiology 36(3), 210-215 (1994).
162. Mascalchi M, Arnetoli G, Inzitari D et al.: Cine-MR imaging of aqueductal CSF flow in normal pressure hydrocephalus syndrome before and after CSF shunt. Acta Radiol. 34(6), 586-592 (1993).
163. Dixon GR, Friedman JA, Luetmer PH et al.: Use of cerebrospinal fluid flow rates measured by phase-contrast MR to predict outcome of ventriculoperitoneal shunting for idiopathic normal-pressure hydrocephalus. Mayo Clin. Proc. 77(6), 509-514 (2002).
164. Parkkola R, Komu M, Kotilainen E, Valtonen S, Thomsen C, Gideon P: Cerebrospinal fluid flow in patients with dilated ventricles studied with MR imaging. Eur. Radiol. 10(9), 1442-1446 (2000).
165. Bradley W Jr, Scalzo D, Queralt J, Nitz W, Atkinson D, Wong P: Normal-pressure hydrocephalus: evaluation with cerebrospinal fluid flow measurements at MR imaging. Radiology 198(2), 523 (1996).
166. Katayama S, Asari S, Ohmoto T: Quantitative measurement of normal and hydrocephalic cerebrospinal fluid flow using phase contrast cine MR imaging. Acta Med. Okayama 47(3), 157 (1993).
167. Egeler-Peerdeman SM, Barkhof F, Walchenbach R, Valk J: Cine phase-contrast MR imaging in normal pressure hydrocephalus patients: relation to surgical outcome. Acta Neurochir Suppl. 71, 340-342 (1998).
168. Luetmer P, Huston J, Friedman J et al.: Measurement of cerebrospinal fluid flow at the cerebral aqueduct by use of phase-contrast magnetic resonance imaging: technique validation and utility in diagnosing idiopathic normal pressure hydrocephalus. Neurosurgery 50(3), 534 (2002).
169. Poca M, Sahuquillo J, Busto M et al.: Agreement between CSF flow dynamics in MRI and ICP monitoring in the diagnosis of normal pressure hydrocephalus. Sensitivity and specificity of CSF dynamics to predict outcome. Acta Neurochir. Suppl. 81, 7 (2002).
170. Kim DS, Choi JU, Huh R, Yun PH, Kim DI: Quantitative assessment of cerebrospinal fluid hydrodynamics using a phase-contrast cine MR image in hydrocephalus. Childs Nerv. Syst. 15(9), 461-467 (1999).
171. Chang LH, Chen CY, Chen MY, Huang TY, Chung HW: Normal and abnormal cerebrospinal fluid dynamics evaluated by optimized cine phase-contrast MR imaging. Zhonghua Fang She Xian Yi Xue Za Zhi 25, 191-195 (2000).
172. Matias S, Ferreira T, Vilela P, Secca M, Goulão A: [Magnetic resonance imaging of aqueductal flow in patients with normal hydrocephalus pressure]. Acta Med. Port. 14(1), 13 (2001).
173. Mase M, Yamada K, Banno T, Miyachi T, Ohara S, Matsumoto T: Quantitative analysis of CSF flow dynamics using MRI in normal pressure hydrocephalus. Acta Neurochir Suppl. 71, 350-353 (1998).
174. Forner J, Florez N, Valero Merino C et al.: [Assessment of reliable quantification of the dynamics of cerebrospinal fluid by magnetic resonance imaging in idiopathic normal pressure hydrocephalus]. Neurologia 22(4), 213 (2007)
175. Al-Zain FT, Rademacher G, Lemcke J, Mutze J, Meier U: [Idiopathic normalpressure hydrocephalus. Flow measurement of cerebrospinal fluid using phase contrast MRI and its diagnostics importance]. Nervenarzt 78(2), 181 (2007)
176. Hakim R, Black P, Portnoy H, Turner M, Goodman J: Correlation between lumboventricular perfusion and MRI-CSF flow studies in idiopathic normal pressure hydrocephalus. Commentary. Surg. Neurol. 49(1), 14-20 (1998).
177. Bateman G, Levi C, Schofield P, Wang Y, Lovett E: The pathophysiology of the aqueduct stroke volume in normal pressure hydrocephalus: can co-morbidity with other forms of dementia be excluded? Neuroradiology 47(10), 741-748 (2005).
178. Kahlon B, Rehncrona S: Is aqueductal stroke volume, measured with cine phase-contrast magnetic resonance imaging scans useful in predicting outcome of shunt surgery in suspected normal pressure hydrocephalus? Neurosurgery 63(6), E1209 (2008).
179. Sharma A, Gaikwad S, Gupta V, Garg A, Mishra N: Measurement of peak CSF flow velocity at cerebral aqueduct, before and after lumbar CSF drainage, by use of phase-contrast MRI: utility in the management of idiopathic normal pressure hydrocephalus. Clin. Neurol. Neurosurg. 110(4), 363-368 (2008).
180. Matsunaga S, Miyati T, Mase M et al.: MRI-intracranial compliance analysis in patients with NPH. Nippon Hoshasen Gijutsu Gakkai Zasshi 62(1), 63 (2006).
181. Mase M, Miyati T, Yamada K, Kasai H, Hara M, Shibamoto Y: Non-invasive measurement of intracranial compliance using cine MRI in normal pressure hydrocephalus. Acta Neurochir. Suppl. 95, 303-306 (2005).
182. Miyati T, Mase M, Kasai H et al.: Noninvasive MRI assessment of intracranial compliance in idiopathic normal pressure hydrocephalus. J. Magn. Reson. Imaging 26(2), 274-278 (2007).
183. Bateman G: The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion. Neuroradiology 45(2), 65-70 (2003).
184. Gideon P, Thomsen C, Gjerris F, Sørensen PS, Ståhlberg F, Henriksen O: Measurement of blood flow in the superior sagittal sinus in healthy volunteers, and in patients with normal pressure hydrocephalus and idiopathic intracranial hypertension with phase-contrast cine MR imaging. Acta Radiol. 37(2), 171-176 (1996).
185. Assaf Y, Ben-Sira L, Constantini S, Chang L, Beni-Adani L: Diffusion tensor imaging in hydrocephalus: initial experience. AJNR Am. J. Neuroradiol. 27(8), 1717 (2006).
186. Keong NC, DeVito E, Harding S, Gillard JH, Pickard JD: O.011 modelling normal pressure hydrocephalus using diffusion tensor imaging. Clin. Neurol. Neurosurg., 110, S4 (2008).
187. Kizu O, Yamada K, Nishimura T: Proton chemical shift imaging in normal pressure hydrocephalus. AJNR Am. J. Neuroradiol. 22(9), 1659-1664 (2001).
188. Braun K, Vandertop W, Gooskens R, Tulleken K, Nicolay K: NMR spectroscopic evaluation of cerebral metabolism in hydrocephalus: a review. Neurol. Res. 22(1), 51 (2000).
189. 1H magnetic resonance spectroscopy in human hydrocephalus. J. Magn. Reson. Imaging 17(3), 291-299 (2003).
190. Shiino A, Nishida Y, Yasuda H, Suzuki M, Matsuda M, Inubushi T: Magnetic resonance spectroscopic determination of a neuronal and axonal marker in white matter predicts reversibility of deficits in secondary normal pressure hydrocephalus. BMJ 75(8), 1141-1148 (2004).
191. del Mar Matarín M, Pueyo R, Poca M et al.: Post-surgical changes in brain metabolism detected by magnetic resonance spectroscopy in normal pressure hydrocephalus: results of a pilot study. BMJ 78(7), 760-763 (2007).
192. Frank R, Hargreaves R: Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2(7), 566-580 (2003).
193. Czerwosz L, Szczepek E, Sokolowska B et al.: Recognition of gait disturbances in patients with normal pressure hydrocephalus using a computer dynography system. J. Physiol. Pharmacol. 59(6), 201-207 (2008).
194. Ravdin LD, Katzen HL, Jackson AE, Tsakanikas D, Assuras S, Relkin NR: Features of gait most responsive to tap test in normal pressure hydrocephalus. Clin. Neurol. Neurosurg. 110(5), 455-461 (2008).
195. Stolze H, Kuhtz-Buschbeck JP, Drucke H, Johnk K, Illert M, Deuschl G: Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. BMJ 70(3), 289-297 (2001).
196. Williams MA, Thomas G, Barbara de Lateur MD et al.: objective assessment of gait in normal-pressure hydrocephalus. Am. J. Phys. Med. Rehabil. 87(1), 39 (2008).
197. Blomsterwall E, Svantesson U, Carlsson U, Tullberg M, Wikkelso C: Postural disturbance in patients with normal pressure hydrocephalus. Acta Neurol. Scand. 102(5), 284 (2000).
198. Seaton BL: Verification of Molecular assays. In: Molecular Diagnostics: for the Clinical Laboratorian (2nd Edition). Coleman WB, Tsongalis GJ (Eds). Humana Press, Inc., Totowa, NJ, USA (2006).
199. Jones HC, Klinge PM: Hydrocephalus 2008, 17-20th September, Hannover Germany: a conference report. Cerebrospinal Fluid Res. 5(1), 19 (2008). ■■ Discusses the latest research trends and findings in chronic adult hydrocephalus.
200. Iseki C, Kawanami T, Nagasawa H et al.: Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: a prospective study in a Japanese population. J. Neurol. Sci. (2008).